Cargando…

How Cholesterol Constrains Glycolipid Conformation for Optimal Recognition of Alzheimer's β Amyloid Peptide (Aβ(1-40))

Membrane lipids play a pivotal role in the pathogenesis of Alzheimer's disease, which is associated with conformational changes, oligomerization and/or aggregation of Alzheimer's β-amyloid (Aβ) peptides. Yet conflicting data have been reported on the respective effect of cholesterol and gl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yahi, Nouara, Aulas, Anaïs, Fantini, Jacques
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2816720/ https://www.ncbi.nlm.nih.gov/pubmed/20140095 http://dx.doi.org/10.1371/journal.pone.0009079

Ejemplares similares

Cholesterol accelerates the binding of Alzheimer's β-amyloid peptide to ganglioside GM1 through a universal hydrogen-bond-dependent sterol tuning of glycolipid conformation
por: Fantini, Jacques, et al.
Publicado: (2013)

Deciphering the Glycolipid Code of Alzheimer's and Parkinson's Amyloid Proteins Allowed the Creation of a Universal Ganglioside-Binding Peptide
por: Yahi, Nouara, et al.
Publicado: (2014)

Common molecular mechanism of amyloid pore formation by Alzheimer’s β-amyloid peptide and α-synuclein
por: Di Scala, Coralie, et al.
Publicado: (2016)

Molecular insights into amyloid regulation by membrane cholesterol and sphingolipids: common mechanisms in neurodegenerative diseases
por: Fantini, Jacques, et al.
Publicado: (2010)

AmyP53 Prevents the Formation of Neurotoxic β-Amyloid Oligomers through an Unprecedent Mechanism of Interaction with Gangliosides: Insights for Alzheimer’s Disease Therapy
por: Azzaz, Fodil, et al.
Publicado: (2023)

Comparison of the amyloid pore forming properties of rat and human Alzheimer’s beta-amyloid peptide 1-42: Calcium imaging data
por: Di Scala, Coralie, et al.
Publicado: (2016)

Anandamide Revisited: How Cholesterol and Ceramides Control Receptor-Dependent and Receptor-Independent Signal Transmission Pathways of a Lipid Neurotransmitter
por: Scala, Coralie Di, et al.
Publicado: (2018)

Leveraging coronavirus binding to gangliosides for innovative vaccine and therapeutic strategies against COVID-19
por: Fantini, Jacques, et al.
Publicado: (2021)

Synergistic antiviral effect of hydroxychloroquine and azithromycin in combination against SARS-CoV-2: What molecular dynamics studies of virus-host interactions reveal
por: Fantini, Jacques, et al.
Publicado: (2020)

Infection-enhancing anti-SARS-CoV-2 antibodies recognize both the original Wuhan/D614G strain and Delta variants. A potential risk for mass vaccination?
por: Yahi, Nouara, et al.
Publicado: (2021)

A Vaccine Strategy Based on the Identification of an Annular Ganglioside Binding Motif in Monkeypox Virus Protein E8L
por: Fantini, Jacques, et al.
Publicado: (2022)

Convergent Evolution Dynamics of SARS-CoV-2 and HIV Surface Envelope Glycoproteins Driven by Host Cell Surface Receptors and Lipid Rafts: Lessons for the Future
por: Fantini, Jacques, et al.
Publicado: (2023)

AmyP53, a Therapeutic Peptide Candidate for the Treatment of Alzheimer’s and Parkinson’s Disease: Safety, Stability, Pharmacokinetics Parameters and Nose-to Brain Delivery
por: Di Scala, Coralie, et al.
Publicado: (2022)

Structural dynamics of SARS-CoV-2 variants: A health monitoring strategy for anticipating Covid-19 outbreaks
por: Fantini, Jacques, et al.
Publicado: (2021)

The Epigenetic Dimension of Protein Structure Is an Intrinsic Weakness of the AlphaFold Program
por: Azzaz, Fodil, et al.
Publicado: (2022)

Electrostatic Surface Potential as a Key Parameter in Virus Transmission and Evolution: How to Manage Future Virus Pandemics in the Post-COVID-19 Era
por: Fantini, Jacques, et al.
Publicado: (2023)

Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection
por: Fantini, Jacques, et al.
Publicado: (2020)

Host Membranes as Drivers of Virus Evolution
por: Matveeva, Mélanie, et al.
Publicado: (2023)

Gene Therapy Strategy for Alzheimer’s and Parkinson’s Diseases Aimed at Preventing the Formation of Neurotoxic Oligomers in SH-SY5Y Cells
por: El-Battari, Assou, et al.
Publicado: (2021)

Is the Conformational Ensemble of Alzheimer’s Aβ10-40 Peptide Force Field Dependent?
por: Siwy, Christopher M., et al.
Publicado: (2017)

Role of spike compensatory mutations in the interspecies transmission of SARS-CoV-2
por: Frutos, Roger, et al.
Publicado: (2022)

Conformational Change of Amyloid-β 40 in Association with Binding to GM1-Glycan Cluster
por: Tachi, Yuhei, et al.
Publicado: (2019)

Structural Dynamics of the SARS-CoV-2 Spike Protein: A 2-Year Retrospective Analysis of SARS-CoV-2 Variants (from Alpha to Omicron) Reveals an Early Divergence between Conserved and Variable Epitopes
por: Guérin, Patrick, et al.
Publicado: (2022)

Amyloid-β peptide 37, 38 and 40 individually and cooperatively inhibit amyloid-β 42 aggregation
por: Braun, Gabriel A., et al.
Publicado: (2022)

Cholesterol as a key player in amyloid β-mediated toxicity in Alzheimer’s disease
por: Rudajev, Vladimir, et al.
Publicado: (2022)

Advantages and disadvantages of the use of the CSF Amyloid β (Aβ) 42/40 ratio in the diagnosis of Alzheimer’s Disease
por: Hansson, Oskar, et al.
Publicado: (2019)

Anandamide-ceramide interactions in a membrane environment: Molecular dynamic simulations data
por: Di Scala, Coralie, et al.
Publicado: (2017)

Allosteric Modulation of PS1/γ-Secretase Conformation Correlates with Amyloid β(42/40) Ratio
por: Uemura, Kengo, et al.
Publicado: (2009)

Molecular insights into the surface-catalyzed secondary nucleation of amyloid-β(40) (Aβ(40)) by the peptide fragment Aβ(16–22)
por: Bunce, Samuel J., et al.
Publicado: (2019)

Structural Studies Providing Insights into Production and Conformational Behavior of Amyloid-β Peptide Associated with Alzheimer’s Disease Development
por: Urban, Anatoly S., et al.
Publicado: (2021)

Amyloid β-peptides 1–40 and 1–42 form oligomers with mixed β-sheets
por: Baldassarre, Maurizio, et al.
Publicado: (2017)

Effects of zinc and carnosine on aggregation kinetics of Amyloid-β40 peptide
por: Shen, Fengyun, et al.
Publicado: (2022)

On the Conformational Dynamics of β-Amyloid Forming Peptides: A Computational Perspective
por: Saravanan, Konda Mani, et al.
Publicado: (2020)

β-Amyloid: the key peptide in the pathogenesis of Alzheimer’s disease
por: Sun, Xiaojuan, et al.
Publicado: (2015)

Metabolism of amyloid β peptide and pathogenesis of Alzheimer’s disease
por: SAIDO, Takaomi C.
Publicado: (2013)

Alignment of Alzheimer’s disease amyloid β-peptide and klotho
por: LEHRER, STEVEN, et al.
Publicado: (2020)

Is plasma amyloid-β 1–42/1–40 a better biomarker for Alzheimer’s disease than AβX–42/X–40?
por: Klafki, Hans-Wolfgang, et al.
Publicado: (2022)

CSF level of β-amyloid peptide predicts mortality in Alzheimer’s disease
por: Boumenir, Adla, et al.
Publicado: (2019)

Different associations between amyloid-βeta 42, amyloid-βeta 40, and amyloid-βeta 42/40 with soluble phosphorylated-tau and disease burden in Alzheimer’s disease: a cerebrospinal fluid and fluorodeoxyglucose-positron emission tomography study
por: Motta, Caterina, et al.
Publicado: (2023)

Head-to-Head Comparison of 8 Plasma Amyloid-β 42/40 Assays in Alzheimer Disease
por: Janelidze, Shorena, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5titp1seum8top74dsh9m1mtcc